Botanix Pharmaceuticals Not Expected to be Impacted by Trump's Executive Orders, Euroz Hartleys Says

MT Newswires Live

2025/05/13

Botanix Pharmaceuticals (ASX:BOT) is currently expected to have little to no impact from the executive order by Trump to lower drug prices in the US, Euroz Hartley said in a Tuesday note.

The research firm noted that the company's drug Sofdra is only approved and sold in the US, lacking an international price for reference.

Provisions in the order related to antitrust enforcement, pharmaceutical exports, or unsafe drug approvals are not relevant to the company or Sofdra, the note added.

Euroz Hartleys maintained Botanix Pharmaceuticals' buy rating with a price target of AU$0.80.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2535764277"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535764277\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2535764277?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-13 12:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535764277","market":"sg","top_or_hot":-1,"title":"Botanix Pharmaceuticals Not Expected to be Impacted by Trump's Executive Orders, Euroz Hartleys Says","media":"MT Newswires Live","content":"<html><body><p> Botanix Pharmaceuticals (ASX:BOT) is currently expected to have little to no impact from the executive order by Trump to lower drug prices in the US, <a href=\"https://laohu8.com/S/EZL.AU\">Euroz</a> Hartley said in a Tuesday note.</p><p>The research firm noted that the company's drug Sofdra is only approved and sold in the US, lacking an international price for reference.</p><p>Provisions in the order related to antitrust enforcement, pharmaceutical exports, or unsafe drug approvals are not relevant to the company or Sofdra, the note added.</p><p>Euroz Hartleys maintained Botanix Pharmaceuticals' buy rating with a price target of AU$0.80.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Botanix Pharmaceuticals Not Expected to be Impacted by Trump's Executive Orders, Euroz Hartleys Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBotanix Pharmaceuticals Not Expected to be Impacted by Trump's Executive Orders, Euroz Hartleys Says\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-05-13 12:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Botanix Pharmaceuticals (ASX:BOT) is currently expected to have little to no impact from the executive order by Trump to lower drug prices in the US, <a href=\"https://laohu8.com/S/EZL.AU\">Euroz</a> Hartley said in a Tuesday note.</p><p>The research firm noted that the company's drug Sofdra is only approved and sold in the US, lacking an international price for reference.</p><p>Provisions in the order related to antitrust enforcement, pharmaceutical exports, or unsafe drug approvals are not relevant to the company or Sofdra, the note added.</p><p>Euroz Hartleys maintained Botanix Pharmaceuticals' buy rating with a price target of AU$0.80.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7096","symbol_name":"製藥","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2535764277","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535764277","pubTimestamp":1747112217,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Botanix Pharmaceuticals (ASX:BOT) is currently expected to have little to no impact from the executive order by Trump to lower drug prices in the US, Euroz Hartley said in a Tuesday note.The research ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7096":"制药","BK7502":"大麻概念","BK7508":"医药生物股","BOT.AU":"BOTANIX PHARMACEUTICALS LTD"},"translate_title":"Euroz Hartleys表示，Botanix Pharmaceuticals预计不会受到特朗普行政命令的影响","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BOT.AU":0.9},"content_text":"Botanix Pharmaceuticals (ASX:BOT) is currently expected to have little to no impact from the executive order by Trump to lower drug prices in the US, Euroz Hartley said in a Tuesday note.The research firm noted that the company's drug Sofdra is only approved and sold in the US, lacking an international price for reference.Provisions in the order related to antitrust enforcement, pharmaceutical exports, or unsafe drug approvals are not relevant to the company or Sofdra, the note added.Euroz Hartleys maintained Botanix Pharmaceuticals' buy rating with a price target of AU$0.80.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}